These findings are suggestive but not diagnostic of H. pylori infection. Magnifying endoscopy can reveal more precisely the abnormal mucosal patterns in an H. pylori-infected stomach; however ...

Rifasutenizol is a novel multi-targeting drug candidate with a synergistic mechanism of action against anaerobic and microaerophile bacteria. It has potential to become the first new drug developed ...

could manage mild infections of Helicobacter pylori (H. pylori) bacteria, though antibiotics are still necessary for complete eradication. “In animals, we’ve seen that some probiotics can ...

H. pylori was successfully cultured in 87% ... of differentiated new drug products for diseases associated with bacterial infection and metabolism. TenNor possesses a unique multi-targeting ...

The topline results found that the TenNor rifasutenizol trial showed better safety and tolerability than the current standard ...

Helicobacter pylori infection is a chronic gastric Gram-negative infection that increases with age worldwide. The prevalence of H. pylori detection appears to decrease in frail patients aged over ...

Helicobacter pylori (H. pylori), and an increased risk of Alzheimer’s. This discovery by a McGill University research team suggests new directions for exploring the role of infections in Alzheimer’s ...

It is also not known whether the bacterial community differs in luminal and mucosal niches. A key question is whether H. pylori influences the bacterial communities of gastroduodenal niches. Design ...